These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 25987636
1. In Vitro Activity of Dalbavancin against Drug-Resistant Staphylococcus aureus Isolates from a Global Surveillance Program. McCurdy SP, Jones RN, Mendes RE, Puttagunta S, Dunne MW. Antimicrob Agents Chemother; 2015 Aug; 59(8):5007-9. PubMed ID: 25987636 [Abstract] [Full Text] [Related]
2. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015). Pfaller MA, Mendes RE, Sader HS, Castanheira M, Flamm RK. J Glob Antimicrob Resist; 2017 Dec; 11():4-7. PubMed ID: 28735053 [Abstract] [Full Text] [Related]
4. In vitro activity of daptomycin combined with dalbavancin and linezolid, and dalbavancin with linezolid against MRSA strains. Aktas G, Derbentli S. J Antimicrob Chemother; 2017 Feb; 72(2):441-443. PubMed ID: 28073963 [Abstract] [Full Text] [Related]
7. In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013). Huband MD, Castanheira M, Farrell DJ, Flamm RK, Jones RN, Sader HS, Mendes RE. Int J Antimicrob Agents; 2016 Jun; 47(6):495-9. PubMed ID: 27211209 [Abstract] [Full Text] [Related]
8. Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011. Sader HS, Flamm RK, Jones RN. Antimicrob Agents Chemother; 2013 Jul; 57(7):3178-81. PubMed ID: 23629712 [Abstract] [Full Text] [Related]
12. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016). Pfaller MA, Flamm RK, Castanheira M, Sader HS, Mendes RE. Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526 [Abstract] [Full Text] [Related]
15. In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients. Rolston KV, Wang W, Nesher L, Shelburne SA, Prince RA. J Antibiot (Tokyo); 2016 May; 69(5):381-7. PubMed ID: 26626876 [Abstract] [Full Text] [Related]
16. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]. Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López F, Gómez M, Grupo VIRA. Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529 [Abstract] [Full Text] [Related]